The Clinical Efficacy of Multidose Oritavancin: A Systematic Review

Oritavancin (ORI) is a semisynthetic lipoglycopeptide approved as a single 1200 mg dose intravenous infusion for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by Gram-positive organisms in adults. The pharmacokinetic/pharmacodynamic (PK/PD) linear kinetic profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baiardi, Giammarco, Cameran Caviglia, Michela, Piras, Fabio, Sacco, Fabio, Prinapori, Roberta, Cristina, Maria Luisa, Mattioli, Francesca, Sartini, Marina, Pontali, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604328/
https://www.ncbi.nlm.nih.gov/pubmed/37887199
http://dx.doi.org/10.3390/antibiotics12101498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604328/
https://www.ncbi.nlm.nih.gov/pubmed/37887199
http://dx.doi.org/10.3390/antibiotics12101498

Ejemplares similares